Controlled activation identifiers for use in ingestible compositions, such as pharma-
informatics enabled compositions, are provided. The identifiers include a controlled …

4,129,125 A 12/1978 Lesteretal. 6'579'23l B1 600% Phi S 4,166,453 A 9/1979 McClelland
6609818 B2 800% C PP 4239 046 A 12/1980 OIl'' Ory 4,269,189 A “981 Abgah 6,612,984 …

Compositions, systems and methods that allow for the detection of the actual physical
delivery of a pharmaceutical agent to a body are provided. Embodiments of the …

(51) Int. Cl. H04Q5/22(2006.01) Compositions, systems and methods that allow for the detec
A6B 5/07(2006.01) tion of the actual physical delivery of a pharmaceutical agent …

The system of the present invention includes a container and an electronic component with
a partial power source in the form of dissimilar materials. The container includes a liquid …

Ingestible event markers having high reliability are provided. Aspects of the ingestible event
markers include a support, a control circuit, a first electrochemical material, a second …

The present invention provides for safe and reliable electronic circuitry that can be employed
in ingestible compositions. The ingestible circuitry of the invention includes a solid Sup port; …

The system of the present invention includes a conductive element, an electronic
component, and a partial power source in the form of dissimilar materials. Upon contact with …

Multi-directional transmitters for in-body devices, such as implantable and ingestible
devices, are provided. Aspects of the in-body multi-direction transmitters of the invention …

No. 8,545,402, which application is a 371 application of International Application No.
PCT/US2010/032590, filed on Apr. 27, 2010, and which application, pursuant to 35 USC …